Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
A1 | 1 | 37 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
A2 | 2 | 37 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
A3 | 3 | 37 | F | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
A4 | 4 | 33 | M | Bladder | High grade urothelial carcinoma with degenerate | * | T3N1M0 | IIIA | Malignant |
A5 | 5 | 33 | M | Bladder | High grade urothelial carcinoma with degenerate | * | T3N1M0 | IIIA | Malignant |
A6 | 6 | 33 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
A7 | 7 | 73 | M | Bladder | High grade urothelial carcinoma(9interstitial) | * | T3aN0M0 | IIIA | Malignant |
A8 | 8 | 73 | M | Bladder | High grade urothelial carcinoma (interstitial) | * | T3aN0M0 | IIIA | Malignant |
A9 | 9 | 73 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
B1 | 10 | 53 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant |
B2 | 11 | 53 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant |
B3 | 12 | 53 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
B4 | 13 | 71 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant |
B5 | 14 | 71 | M | Bladder | High grade urothelial carcinoma | * | T3bN0M0 | IIIA | Malignant |
B6 | 15 | 71 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
B7 | 16 | 51 | M | Bladder | Squamous cell carcinoma | 2 | T2bN2M0 | IIIB | Malignant |
B8 | 17 | 51 | M | Bladder | Squamous cell carcinoma | 2 | T2bN2M0 | IIIB | Malignant |
B9 | 18 | 51 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
C1 | 19 | 72 | M | Bladder | Squamous cell carcinoma | 2--3 | T3bN0M0 | IIIA | Malignant |
C2 | 20 | 72 | M | Bladder | Squamous cell carcinoma | 2--3 | T3bN0M0 | IIIA | Malignant |
C3 | 21 | 72 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
C4 | 22 | 52 | M | Bladder | Squamous cell carcinoma | 3 | T3N0M0 | IIIA | Malignant |
C5 | 23 | 52 | M | Bladder | Squamous cell carcinoma | 3 | T3N0M0 | IIIA | Malignant |
C6 | 24 | 52 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
C7 | 25 | 60 | M | Bladder | Small cell carcinoma | * | T2N1M0 | IIIA | Malignant |
C8 | 26 | 60 | M | Bladder | Small cell carcinoma | * | T2N1M0 | IIIA | Malignant |
C9 | 27 | 60 | M | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
D1 | 28 | 50 | F | Bladder | Small cell carcinoma | * | T2N1M0 | IIIA | Malignant |
D2 | 29 | 50 | F | Bladder | Small cell carcinoma | * | T2N1M0 | IIIA | Malignant |
D3 | 30 | 50 | F | Bladder | Cancer adjacent bladder tissue | * | * | * | AT |
D4 | 31 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
D5 | 32 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
D6 | 33 | 72 | M | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
D7 | 34 | 45 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
D8 | 35 | 45 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
D9 | 36 | 45 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
E1 | 37 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
E2 | 38 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
E3 | 39 | 59 | F | Bladder | Low-grade urothelial carcinoma | * | T1N0M0 | I | Malignant |
E4 | 40 | 61 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant |
E5 | 41 | 61 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant |
E6 | 42 | 61 | M | Bladder | Low-grade urothelial carcinoma | * | T2N0M0 | II | Malignant |
E7 | 43 | 57 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant |
E8 | 44 | 57 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant |
E9 | 45 | 57 | F | Bladder | High grade urothelial carcinoma | * | T3N0M0 | IIIA | Malignant |
F1 | 46 | 37 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
F2 | 47 | 37 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
F3 | 48 | 37 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
F4 | 49 | 42 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
F5 | 50 | 42 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
F6 | 51 | 42 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
F7 | 52 | 48 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
F8 | 53 | 48 | F | Cervix | Squamous cell carcinoma with degenerate | 2 | T1b1N0M0 | IB1 | Malignant |
F9 | 54 | 48 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
G1 | 55 | 40 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
G2 | 56 | 40 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
G3 | 57 | 40 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
G4 | 58 | 42 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
G5 | 59 | 42 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
G6 | 60 | 42 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
G7 | 61 | 48 | F | Cervix | Adenosquamous carcinoma | 2--3 | * | * | Malignant |
G8 | 62 | 48 | F | Cervix | Adenosquamous carcinoma | 2--3 | * | * | Malignant |
G9 | 63 | 48 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
H1 | 64 | 56 | F | Cervix | Squamous cell carcinoma | 2--3 | T1b1N0M0 | IB1 | Malignant |
H2 | 65 | 56 | F | Cervix | Squamous cell carcinoma | 2--3 | T1b1N0M0 | IB1 | Malignant |
H3 | 66 | 56 | F | Cervix | Cancer adjacent cervix tissue | * | * | * | AT |
H4 | 67 | 46 | F | Cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant |
H5 | 68 | 46 | F | Cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant |
H6 | 69 | 46 | F | Cervix | Squamous cell carcinoma | 2 | T1bN0M0 | IB | Malignant |
H7 | 70 | 44 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
H8 | 71 | 44 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
H9 | 72 | 44 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant |
I1 | 73 | 39 | F | Cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant |
I2 | 74 | 39 | F | Cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant |
I3 | 75 | 39 | F | Cervix | Squamous cell carcinoma | 2 | T1N0M0 | I | Malignant |
I4 | 76 | 24 | F | Cervix | Squamous cell carcinoma | 2 | T2aN0M0 | IIA | Malignant |
I5 | 77 | 24 | F | Cervix | Squamous cell carcinoma | 2 | T2aN0M0 | IIA | Malignant |
I6 | 78 | 24 | F | Cervix | Squamous cell carcinoma | 2 | T2aN0M0 | IIA | Malignant |
I7 | 79 | 60 | F | Cervix | Squamous cell carcinoma | 3 | T1N0M0 | I | Malignant |
I8 | 80 | 60 | F | Cervix | Squamous cell carcinoma | 3 | T1N0M0 | I | Malignant |
I9 | 81 | 60 | F | Cervix | Squamous cell carcinoma | 3 | T1N0M0 | I | Malignant |
Tissue Marker |